|
2
|
Haas NA, Kock L, Bertram H, Boekenkamp R, De Wolf D, Ditkivskyy I, Freund MW, Gewillig M, Happel CM, Herberg U, Karthasyan E, Kozlik-Feldmann R, Kretschmar O, Kuzmenko Y, Milanesi O, Mueller G, Pongiglione G, Schubert S, Tarusinov G, Kampmann C. Interventional VSD-Closure with the Nit-Occlud ® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry. Pediatr Cardiol 2017; 38:215-227. [PMID: 27847970 DOI: 10.1007/s00246-016-1502-8] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2016] [Accepted: 10/26/2016] [Indexed: 11/25/2022]
Abstract
In August 2010, the Nit-Occlud® Lê (EUREVECO) became available for transcatheter coil occlusion of ventricular septal defects (VSDs). Retrospective European Registry for VSD Closure using the Nit-Occlud® Lê-VSD-Coil; analysis of the feasibility, results, safety and follow-up of VSD-closure over a 3-year period in 18 European centers. In 102 of 111 patients (female 66), successful VSD closure was performed (mean age 8.2 years, mean weight 28.82 kg), 81 perimembranous VSDs (48 with aneurysm), 30 muscular VSDs, mean procedure time was 121.1 min, and mean fluoroscopy time was 26.3 min. Short- and midterm term follow-up was possible in 100/102 patients, there was 1 embolization and 1 explantation after 24 months. Immediate complete closure occurred in 49 of 101 patients (48.5%), trivial residual shunt was present in 51 (50.0%), closure rate was 95% after 6 months and 97% after 1 year. Out of the 102 patients, there were 2 severe complications (1.8%) (1 severe hemolysis, 1 embolization) and 8 moderate/transient (=7.2%) including 1 transient AV block. During a mean follow-up period of 31.3 months (range 24-48) and a total follow-up time of 224.75 patient years, no further problems occurred. VSD closure with the Nit-Occlud® Lê VSD coil is feasible and safe with a minimal risk of severe side effects. The long-term effects and safety require further clinical follow-up studies.
Collapse
Affiliation(s)
- Nikolaus A Haas
- Department for Congenital Heart Defects, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Georgstrasse 11, 32545, Bad Oeynhausen, Germany.
- Department of Pediatric Cardiology and Pediatric Intensive Care, Klinikum der Ludwigs Maximilian Universität München, Munich, Germany.
| | - Laura Kock
- Department for Congenital Heart Defects, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Georgstrasse 11, 32545, Bad Oeynhausen, Germany
| | - Harald Bertram
- Department of Pediatric Cardiology and Pediatric Intensive Care, Children's Hospital Hannover Medical School, Hannover, Germany
| | - Regina Boekenkamp
- Department for Pediatric Cardiology, Leiden University Medical Center, Leiden, Netherlands
| | - Daniel De Wolf
- Department for Pediatric Cardiology, Ghent University Hospital, UZ Ghent, Ghent, Belgium
| | - Igor Ditkivskyy
- Department of Interventional Cardiology, National Amosov Institute of Cardio-Vascular Surgery, Kiev, Ukraine
| | - Matthias W Freund
- Department for Pediatric Cardiology, University Medical Center Utrecht, Utrecht, Netherlands
| | - Marc Gewillig
- Department for Pediatric Cardiology, University Hospital Leuven, Louvain, Belgium
| | - Christoph M Happel
- Department for Congenital Heart Defects, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Georgstrasse 11, 32545, Bad Oeynhausen, Germany
| | - Ulrike Herberg
- Department for Pediatric Cardiology, University Hospital Bonn, Bonn, Germany
| | - Edvard Karthasyan
- Center for Congenital Heart Defects and Pediatric Cardiology, Research Institution for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
| | - Rainer Kozlik-Feldmann
- Department of Pediatric Cardiology and Pediatric Intensive Care, Klinikum der Ludwigs Maximilian Universität München, Munich, Germany
| | - Oliver Kretschmar
- Department for Pediatric Cardiology/Congenital Heart Defects, University Children's Hospital Zurich, Zurich, Switzerland
| | - Yulia Kuzmenko
- Department of Pediatric Cardiology, The Scientific Practical Children's Cardiac Center, Kiev, Ukraine
| | - Ornella Milanesi
- Department of Women and Children's Health Pediatric Cardiac Unit, University Hospital of Padova, Padua, Italy
| | - Goetz Mueller
- Department for Pediatric Cardiology, University Heart Centre Hamburg, Hamburg, Germany
| | - Giacomo Pongiglione
- Department for Pediatric Cardiology and Pediatric Cardiac Surgery, Bambino Gesú Children's Hospital, Rome, Vatican, Italy
| | - Stephan Schubert
- Department for Congenital Heart Defects/Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany
| | - Gleb Tarusinov
- Center for Congenital Heart Defects, Pediatric Cardiology, Heart Centre Duisburg, Evangelic Hospital Niederrhein, Duisburg, Germany
| | - Christoph Kampmann
- Department for Pediatric Cardiology, University Children's Hospital, Mainz, Germany
| |
Collapse
|
|
3
|
YANG LINQI, TAI BEECHOO, KHIN LAYWAI, QUEK SWEECHYE. A Systematic Review on the Efficacy and Safety of Transcatheter Device Closure of Ventricular Septal Defects (VSD). J Interv Cardiol 2014; 27:260-72. [DOI: 10.1111/joic.12121] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Affiliation(s)
- LINQI YANG
- Department of Paediatrics; National University Health System; National University of Singapore; Singapore
| | - BEE-CHOO TAI
- Saw Swee Hock School of Public Health; National University of Singapore; Singapore Singapore
| | - LAY WAI KHIN
- Saw Swee Hock School of Public Health; National University of Singapore; Singapore Singapore
| | - SWEE CHYE QUEK
- Department of Paediatrics; National University Health System; National University of Singapore; Singapore
| |
Collapse
|
|
4
|
Abstract
Aims The aim of this systematic review is to gain insight into the published experience on percutaneous closure of a post-infarction ventricular septal rupture (VSR). Method Relevant literature was obtained by MeSH-term searches in the online search-engine PubMed. Articles published in the last 10 years were included. Further filtering was done by using search limits and individual article selection based on the aims of this systematic review. Conclusion Percutaneous closure is a potential technique in a select group of patients. The presence of cardiogenic shock and closure in the acute phase after VSR diagnosis are important risk factors of mortality. Device implantation is in general successful with few procedure-related complications. Reduction of the shunt fraction has been reported frequently. This technique is a less invasive alternative to surgical treatment and should be applied on a case-by-case basis.
Collapse
|